DEBORAH GUNDEN: Open Payments
NPI 1376514380 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 33 payments from 8 companies in 2025. Trend: 2023 $1,467 · 2024 $1,319 · 2025 $520
Food & beverage: $520
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $251 |
| Phathom Pharmaceuticals, Inc. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Janssen Biotech, Inc. | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 2 | $33 |
| Ardelyx, Inc. | 2 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
Products named: RINVOQ, VOQUEZNA, ENTYVIO, SKYRIZI, VIBERZI, LINZESS, TREMFYA, REBYOTA.
Industry payments across IN — which companies pay providers there.
